ACLARUSDX Trademark

Trademark Overview


On Tuesday, August 24, 2010, a trademark application was filed for ACLARUSDX with the United States Patent and Trademark Office. The USPTO has given the ACLARUSDX trademark a serial number of 79091998. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, August 24, 2020. This trademark is owned by ExonHit Therapeutics. The ACLARUSDX trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Chemical preparations and compositions, namely, nucleic acids attached to a solid medium, for industrial and scientific use; chemical fissile preparations for laboratory use; chemical fissile preparations for scientific research; chemical preparations for nucleic acids attached to a solid medium, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely, blood for enabling the quantification of nucleic acid content; chemicals for scientific use, other than for medical or veterinary purposes; chemical preparations or reagents for laboratory, namely, nucleic acid to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, nucleic acid libraries to screen and analyze gene expression, to ide...

Pharmaceutical preparations for treating neurodegenerative diseases, particularly Alzheimer's disease; diagnostic reagents and media for medical use, namely, reagents and media for use in testing blood biomarkers, to enable the identification of patients suffering from Alzheimer's disease or at risk of developing the disease and for enabling the identification of patients responding to specific treatments; acidic biological preparations and products for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing Alzheimer's disease; capsules for diagnostic tests and medicines sold empty; chemico-pharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; biopharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; chemicals for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing neurodegenerative diseases, especially Alzheimer's disease; medical and clinical diagnosis testing kits c...

Surgical, medical, dental and veterinary apparatus and instruments, namely, apparatus and instruments for use in identifying, assessing the seriousness of, assessing the prognoses of, measuring the progression of and measuring the conversion of neurodegenerative diseases such as Alzheimer's; medical apparatus using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus for medical diagnostic purposes, namely, kits for taking blood samples comprising medical instruments for taking blood, DNA chips for diagnosing Alzheimer's disease, and material required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions; spoons for medicines; containers specially adapted for the application of medicines, namely, bags and pouches used in the delivery of medication; probes for medical purposes; syringes for medical purposes; galvanic therapeutic devices for diagnosing neurodegenerative diseases, especially Alzhei...

Research and development for others of pharmaceutical molecules or biological markers and medicines for diagnosing and treating neurodegenerative diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues, and blood samples; biotechnological project studies to identify people suffering from Alzheimer's disease and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content for medical and scientific research purposes

Medical services; veterinary services; medical assistance; consulting in the fields of biotechnology and pharmacy, namely, to assist in the selection of Alzheimer's sufferers for clinical trials and to offer personalized treatments; hospitals; pharmacist's services to make up prescriptions; pharmaceutical advice; medical services, namely, facilitating the diagnosis and care of geriatric patients and patients with neurodegenerative diseases; health care; telemedicine services
aclarusdx

General Information


Serial Number79091998
Word MarkACLARUSDX
Filing DateTuesday, August 24, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, August 24, 2020
Registration Number4024702
Registration DateTuesday, September 13, 2011
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 28, 2011

Trademark Statements


Indication of Colors claimedThe color(s) red and blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the wording "ACLARUSDX", with "ACLARUS" in blue and "DX" in red".
Goods and ServicesChemical preparations and compositions, namely, nucleic acids attached to a solid medium, for industrial and scientific use; chemical fissile preparations for laboratory use; chemical fissile preparations for scientific research; chemical preparations for nucleic acids attached to a solid medium, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely, blood for enabling the quantification of nucleic acid content; chemicals for scientific use, other than for medical or veterinary purposes; chemical preparations or reagents for laboratory, namely, nucleic acid to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, nucleic acid libraries to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, DNA biochips for decoding genes affected by the Alzheimer's disease or revealing the transcriptomic signature of patients affected with Alzheimer's disease, and DNA chips to make visible and analyze gene expression in the fields of human and pharmacological medicine and veterinary science
Goods and ServicesPharmaceutical preparations for treating neurodegenerative diseases, particularly Alzheimer's disease; diagnostic reagents and media for medical use, namely, reagents and media for use in testing blood biomarkers, to enable the identification of patients suffering from Alzheimer's disease or at risk of developing the disease and for enabling the identification of patients responding to specific treatments; acidic biological preparations and products for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing Alzheimer's disease; capsules for diagnostic tests and medicines sold empty; chemico-pharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; biopharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; chemicals for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing neurodegenerative diseases, especially Alzheimer's disease; medical and clinical diagnosis testing kits comprised of nucleic acid banks, nucleic acids on DNA chips and testing probes; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences for use on biochips, for medical and medical diagnostic use, namely, for decoding genes affected by Alzheimer's disease or revealing the transcriptomic signature of patients suffering from Alzheimer's disease; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzyme substrates used as ingredients in medicines for treatment of Alzheimer's disease; reagents contained in diagnostic test kits for taking blood samples, for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions
Goods and ServicesSurgical, medical, dental and veterinary apparatus and instruments, namely, apparatus and instruments for use in identifying, assessing the seriousness of, assessing the prognoses of, measuring the progression of and measuring the conversion of neurodegenerative diseases such as Alzheimer's; medical apparatus using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus for medical diagnostic purposes, namely, kits for taking blood samples comprising medical instruments for taking blood, DNA chips for diagnosing Alzheimer's disease, and material required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions; spoons for medicines; containers specially adapted for the application of medicines, namely, bags and pouches used in the delivery of medication; probes for medical purposes; syringes for medical purposes; galvanic therapeutic devices for diagnosing neurodegenerative diseases, especially Alzheimer's disease
Goods and ServicesResearch and development for others of pharmaceutical molecules or biological markers and medicines for diagnosing and treating neurodegenerative diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues, and blood samples; biotechnological project studies to identify people suffering from Alzheimer's disease and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content for medical and scientific research purposes
Goods and ServicesMedical services; veterinary services; medical assistance; consulting in the fields of biotechnology and pharmacy, namely, to assist in the selection of Alzheimer's sufferers for clinical trials and to offer personalized treatments; hospitals; pharmacist's services to make up prescriptions; pharmaceutical advice; medical services, namely, facilitating the diagnosis and care of geriatric patients and patients with neurodegenerative diseases; health care; telemedicine services
Pseudo MarkACLARUS DX

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, December 5, 2014
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, December 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, December 5, 2014
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, December 5, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateFriday, December 5, 2014
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEXONHIT S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameExonHit Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressF-75013 Paris
FR

Party NameExonHit Therapeutics
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressF-75013 Paris
FR

Trademark Events


Event DateEvent Description
Friday, September 10, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, September 10, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, September 25, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 2, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 2, 2015INVALIDATION PROCESSED
Wednesday, August 5, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 5, 2014CANCELLED SECTION 7-TOTAL
Friday, December 5, 2014CANCELLATION TERMINATED NO. 999999
Wednesday, December 3, 2014CANCELLATION DENIED NO. 999999
Friday, October 24, 2014CANCELLATION INSTITUTED NO. 999999
Sunday, May 19, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 23, 2011FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 23, 2011FINAL DISPOSITION PROCESSED
Tuesday, December 13, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 15, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, September 13, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, June 28, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2011PUBLISHED FOR OPPOSITION
Thursday, May 26, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 26, 2011ASSIGNED TO LIE
Thursday, May 12, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 12, 2011EXAMINER'S AMENDMENT ENTERED
Thursday, May 12, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 12, 2011EXAMINERS AMENDMENT E-MAILED
Thursday, May 12, 2011EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 26, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 26, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 26, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 26, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 27, 2011REFUSAL PROCESSED BY IB
Wednesday, February 9, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 9, 2011REFUSAL PROCESSED BY MPU
Wednesday, February 9, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 8, 2011NON-FINAL ACTION WRITTEN
Tuesday, February 8, 2011APPLICATION FILING RECEIPT MAILED
Friday, February 4, 2011ASSIGNED TO EXAMINER
Friday, February 4, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 3, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB